Insider Transactions in Q3 2021 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,593
-4.27%
|
$57,046
$22.15 P/Share
|
|
Sep 10
2021
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,943
+5.52%
|
$34,715
$5.72 P/Share
|
|
Sep 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.24%
|
$145,825
$25.82 P/Share
|
|
Sep 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.48%
|
$145,825
$25.24 P/Share
|
|
Aug 11
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
621
-0.05%
|
$15,525
$25.15 P/Share
|
|
Aug 11
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,917
-0.16%
|
$47,925
$25.07 P/Share
|
|
Aug 10
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
103
-0.01%
|
$2,575
$25.0 P/Share
|
|
Aug 09
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
827
-0.03%
|
$20,675
$25.07 P/Share
|
|
Aug 09
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
700
-0.06%
|
$17,500
$25.0 P/Share
|
|
Aug 06
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,616
-0.13%
|
$40,400
$25.0 P/Share
|
|
Aug 06
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
3,129
-0.25%
|
$78,225
$25.0 P/Share
|
|
Aug 05
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,370
-0.11%
|
$34,250
$25.0 P/Share
|
|
Aug 05
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
1,383
-0.04%
|
$34,575
$25.0 P/Share
|